Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC.NAVB · Entity 107761 | Director | November 15, 2021 | December 02, 2021 |
| VIRCO MFG CORPORATIONVIRC · Entity 6794 | Director | June 16, 2026 | June 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NAVIDEA BIOPHARMACEUTICALS, INC.
Report date November 15, 2021 · Filed December 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,600 |
Ending reported balance
After 2021-11-30 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-11-15 · Grant · Acquired 30,000 · Balance 30,000 F1: Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant. Row 2 · 2021-11-15 · Grant · Acquired 2,350 · Balance 32,350 F2: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees. Row 3 · 2021-11-30 · Grant · Acquired 1,250 · Balance 33,600 F3: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant.
F2: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.
F3: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
VIRCO MFG CORPORATION
Report date June 16, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 par valueSEC Table I · non-derivative | Direct | 94,342 |
Reported balance
After 2026-06-16 transaction · row 1
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 8,064 · Balance 94,342 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 17, 2026 21:59 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon Stock $.01 par value | 8,064 | $6.20 | $49,996.80 |
DisclosureSEC source: 0001353343-26-000001 · wk-form4_1781733552.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,342 Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 17:19 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon Stock $.01 par value | 6,134 | $8.14 | $49,930.76 |
DisclosureSEC source: 0001628280-25-032306 · wk-form4_1750439958.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,278 F1 · shares: Represents a grant of restricted stock vesting on June 17, 2025 Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 17:15 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon Stock $.01 par value | 3,213 | $15.55 | $49,962.15 |
DisclosureSEC source: 0001628280-24-029255 · wk-form4_1718990103.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,144 Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 21:43 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon stock $.01 par value | 19,230 | $3.89 | $74,804.70 |
DisclosureSEC source: 0001209191-23-038855 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,931 F1 · shares: Represents a grant of restricted stock vesting on June 20, 2024 Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 20:49 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | PurchaseCommon stock $.01 par value | 2,000 | $4.76 | $9,520.00 |
DisclosureSEC source: 0001209191-22-050740 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,701 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 16:14 UTC | NAVIDEA BIOPHARMACEUTICALS, INC. NAVB · Entity 107761 | GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027699 · rdgdoc.xml · nonDerivative · entry 3 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,600 F3 · shares: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees. Read SEC document |
| November 15, 2021 Filed Dec 2, 2021 16:14 UTC | NAVIDEA BIOPHARMACEUTICALS, INC. NAVB · Entity 107761 | GrantCommon Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027699 · rdgdoc.xml · nonDerivative · entry 2 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,350 F2 · shares: Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees. Read SEC document |
| November 15, 2021 Filed Dec 2, 2021 16:14 UTC | NAVIDEA BIOPHARMACEUTICALS, INC. NAVB · Entity 107761 | GrantCommon Stock | 30,000 | $0.00 | $30.00 |
DisclosureSEC source: 0001437749-21-027699 · rdgdoc.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of the first three anniversaries of the date of grant. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 21:46 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon stock $.01 par value | 13,774 | $3.62 | $49,861.88 |
DisclosureSEC source: 0001209191-21-043721 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,701 F1 · shares: Represents a grant of restricted stock vesting on June 28, 2022 Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 17:00 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon stock $.01 par value | 18,939 | $2.64 | $49,998.96 |
DisclosureSEC source: 0001209191-20-037186 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,927 F1 · shares: Represents a grant of restricted stock vesting on June 16, 2021, of 18,939 shares. Read SEC document |
| June 18, 2019 Filed Jun 19, 2019 20:49 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon stock $.01 par value | 11,877 | $4.21 | $50,002.17 |
DisclosureSEC source: 0001209191-19-038058 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,988 F1 · shares: Represents a grant of restricted stock vesting on June 18, 2020, of 11,877 shares. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:19 UTC | VIRCO MFG CORPORATION VIRC · Entity 6794 | GrantCommon stock $.01 par value | 11,111 | $4.50 | $49,999.50 |
DisclosureSEC source: 0001209191-18-038741 · doc4.xml · nonDerivative · entry 1 Winkler Agnieszka · CIK 0001353343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111 F1 · price: Represents a grant of restricted stock vesting on June 19, 2019 of 11,111 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.